On the other hand, SNPs in the mTOR pathway genes, BDNF, HOMER1 and DAT have been implicated in either increased or reduced risk for dyskinesias, but with single studies that are yet to be corroborated in larger cohorts. This evidence concerns the gene SLC6A3 and drug-induced dyskinesia.